Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised

Submitted by Anonymous (not verified) on 18 July 2024 - 10:26

Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised

Committee for Orphan Medicinal Products (COMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024

Submitted by Anonymous (not verified) on 17 July 2024 - 15:23

Committee for Orphan Medicinal Products (COMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024

Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa

Submitted by Anonymous (not verified) on 17 July 2024 - 15:11

Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa

Committee for Advanced Therapies (CAT): 17-19 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 17 July 2024 to 19 July 2024

Submitted by Anonymous (not verified) on 17 July 2024 - 15:07

Committee for Advanced Therapies (CAT): 17-19 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 17 July 2024 to 19 July 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness